↓ Skip to main content

Dove Medical Press

Gene Therapy for Rdh12-Associated Retinal Diseases Helps to Delay Retinal Degeneration and Vision Loss

Overview of attention for article published in Drug Design, Development and Therapy, August 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
11 Mendeley
Title
Gene Therapy for Rdh12-Associated Retinal Diseases Helps to Delay Retinal Degeneration and Vision Loss
Published in
Drug Design, Development and Therapy, August 2021
DOI 10.2147/dddt.s305378
Pubmed ID
Authors

Jiaxin Bian, Hongyu Chen, Junhui Sun, Yuqing Cao, Jianhong An, Qing Pan, Ming Qi

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 18%
Researcher 2 18%
Student > Bachelor 1 9%
Student > Doctoral Student 1 9%
Student > Ph. D. Student 1 9%
Other 1 9%
Unknown 3 27%
Readers by discipline Count As %
Unspecified 2 18%
Biochemistry, Genetics and Molecular Biology 1 9%
Nursing and Health Professions 1 9%
Psychology 1 9%
Medicine and Dentistry 1 9%
Other 1 9%
Unknown 4 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2021.
All research outputs
#14,528,477
of 25,604,262 outputs
Outputs from Drug Design, Development and Therapy
#775
of 2,271 outputs
Outputs of similar age
#189,375
of 441,714 outputs
Outputs of similar age from Drug Design, Development and Therapy
#17
of 56 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,714 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.